Synapse Open Synapse
Biology

STAT+: FDA rejects Capricor Therapeutics’ Duchenne therapy, a decision that was a long time coming

STAT News · · 1 min read

The FDA said it had rejected a cell therapy intended for patients with Duchenne muscular dystrophy developed by Capricor Therapeutics.

Latest from STAT News